SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-23-024684
Filing Date
2023-07-17
Accepted
2023-07-17 12:10:36
Documents
1
Effectiveness Date
2023-07-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11898
  Complete submission text file 0001493152-23-024684.txt   13247
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-487073 | Film No.: 231091000
SIC: 2834 Pharmaceutical Preparations